OPENING IN SPRING 2011!
InterVac Overview
Click for our new InterVac video!
When InterVac opens in 2011, research capabilities within VIDO-InterVac will grow exponentially.
InterVac will alleviate the current worldwide shortage of Containment Level 3 laboratory space for vaccine research and development.
Our research addresses infectious diseases of importance to human and animal health, and involves:
- developing new vaccines and improving existing ones
- improving methods for administering vaccines in both animals and humans
- improving the safety of food and water
- providing international calibre training for graduate students and scientists from around the world
InterVac construction is being funded by:
- Government of Canada
- Canada Foundation for Innovation
- Government of Saskatchewan
- University of Saskatchewan
- City of Saskatoon
Building InterVac
Construction on InterVac is progressing well ....View our webcam to see for yourself!
- Last hour animated
- Last 24 hours animated
- Time lapse from start of construction
Benefits of InterVac
For Society:
- Canada’s strategy for dealing with infectious diseases will be strengthened.
- Working with the Public Health Agency of Canada and the Canadian Food Inspection Agency, Canada will be able to respond faster to emerging diseases affecting animals and humans.
For Researchers:
- Understanding of CL3 infectious diseases and the interactions between human and animal health will be better understood.
- InterVac's distinctive design will accommodate research ranging from preclinical testing to licensing trials.
For Animal and Human Health Industries:
- Agricultural and biopharmaceutical industries that address animal and human health issues will be enhanced.
- R&D on infectious diseases of agricultural and economic significance will be strengthened.
For Saskatchewan and Canada:
- InterVac will provide unparalleled research, teaching and graduate study opportunities.
- Saskatchewan’s international leadership in vaccine development will be secured.
- About 400 construction jobs and 50 full-time research-related employment positions will be added to the province.
- About VIDO-InterVac
- Introducing InterVac
- Our Research
- Newsroom
- Patents and Publications
- Information For Livestock Producers
- Opportunities at VIDO-InterVac
- Links
- Gairdner International Vaccine Symposium
Immunization has been a great public health success story. The lives of millions of children have been saved, millions have the chance of a longer healthier life, a greater chance to learn, to play, to read and write, to move around freely without suffering.
Nelson Mandela, Winner of the Nobel Peace Prize, 1993
